Medical News

RSS

McKesson to acquire US Oncology

McKesson Corporation, a leading healthcare services and information technology company, and US Oncology, a leading integrated oncology company, announced today that the two companies have signed a definitive agreement under which McKesson will purchase all outstanding shares of US Oncology for cash.

1 Nov 2010

Vascular Pathways closes $14 million Series B equity financing round

Vascular Pathways Inc., a privately held medical device company with a breakthrough product for peripheral intravenous access, today announced that the company has closed a Series B preferred equity financing round of $14 million with premier venture capital firms active in medical technology.

1 Nov 2010

Endo third quarter total revenues increase 23% to $444.1 million

Endo Pharmaceuticals today reported financial results for the third quarter 2010.

1 Nov 2010

Life Technologies announces launch of new sequencer to deliver genomic data

Life Technologies Corporation a provider of innovative life science solutions, today announced the launch of the 5500xl SOLiD Sequencer, a new instrument designed to deliver the industry's fastest and most accurate genomic data for cancer biology and genetic disease research.

1 Nov 2010

First Edition: November 1, 2010

In today's health policy headlines, how will Tuesday's election impact the health law?

1 Nov 2010

Spectrum submits complete response to FDA's CRL for FUSILEV to treat colorectal cancer

Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology, today announced that on Friday, October 29, 2010 it submitted a complete response to the "Complete Response" letter issued by the U.S. Food and Drug Administration (FDA), regarding its supplemental New Drug Application (sNDA) for FUSILEV (levoleucovorin) for Injection for treatment of patients with advanced metastatic colorectal cancer.

1 Nov 2010

FDA grants Clinical Data's PRX-8066 Orphan Drug Designation for pulmonary arterial hypertension

Clinical Data, Inc. today announced that the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for pulmonary arterial hypertension (PAH) to PRX-8066, the Company's selective serotonin 2B (5-HT2B) receptor antagonist.

1 Nov 2010

Inhibitex announces initiation of INX-189 Phase 1b clinical trial for HCV infection

Inhibitex, Inc. announced today that it has initiated a Phase 1b, multiple ascending dose (MAD) clinical trial of INX-189, its nucleotide polymerase inhibitor in development for the treatment of chronic infections caused by hepatitis C virus (HCV).

1 Nov 2010

American Anesthesiology acquires Greensboro Anesthesia Physicians

American Anesthesiology, a subsidiary of MEDNAX, Inc., today announced the acquisition of Greensboro Anesthesia Physicians, P.C., a physician group practice that provides patient services at three hospitals within the Moses Cone Health System and two surgery centers in the Greensboro, NC, metropolitan area.

1 Nov 2010

Consumer Reports publishes survey on eyeglass retailers

Shopping for eyeglasses isn't easy, especially when frames can cost well over $200 a pair, even without the fancy add-ons and logos. But a Consumer Reports survey found that a great pair of eyeglasses doesn't have to break the bank.

1 Nov 2010

Catalina Marketing's blueprint can help shoppers to make positive choices in nutrition, lifestyle management

A new consumer attitude research study conducted by Catalina Marketing, the global leader in shopper-driven marketing solutions, reveals that, despite the industry's healthy-eating consumer initiatives, shoppers have not changed their old buying habits, behavior and perceptions.

1 Nov 2010

BetterRxCard helps McLennan County residents save on prescription drugs

BetterRxCard, the free prescription discount card sponsored by McLennan County, today announced the program has saved $138,562 for McLennan County residents during its initial six months. "Anything we can do to assist in reducing or deferring the costs to our citizens we are glad to participate in," said McLennan County Judge Jim Lewis.

1 Nov 2010

Global Genes Project launches new campaign to create awareness about rare diseases

The Global Genes Project, a non-profit advocacy organization that aims to raise awareness about the prevalence of rare diseases worldwide, today launched the 7,000 Bracelets for Hope campaign. The 7,000 Bracelets for Hope campaign is designed to draw attention to an estimated 7,000 different chronic, life-threatening and fatal rare diseases and disorders affecting approximately 30 million Americans and millions more globally.

1 Nov 2010

Seven tips for navigating Medicare maze

If you're about to turn 65, you'll be part of the first wave of baby boomers signing up for Medicare. Consumer Reports Health recommends signing up as early as three months ahead of your birthday. Failing to do so could potentially cost you thousands of dollars down the road. That's one of seven tips for navigating the Medicare maze available in the December issue of Consumer Reports and online at www.ConsumerReportsHealth.org.

1 Nov 2010

Wireless test solutions company LitePoint joins Continua Health Alliance

LitePoint Corporation, the leader in wireless test solutions, announced today it has joined Continua Health Alliance, along with other technology leaders.

1 Nov 2010

Catalyst’s CPP-115 improves retinal safety profile than vigabatrin

Catalyst Pharmaceutical Partners, Inc. today announced positive results from a series of CPP-115 preclinical safety and efficacy evaluations. CPP-115 was found to have a significantly improved retinal safety profile compared to vigabatrin.

1 Nov 2010

Biodel receives FDA CRL for Linjeta NDA

Biodel Inc. announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) requesting additional information regarding the company's new drug application (NDA) for Linjeta™ (human insulin [rDNA origin]) injection 100IU/mL for the treatment of type 1 and type 2 diabetes mellitus to improve glycemic control.

1 Nov 2010

Acorda reports net income of $12.4 million for third quarter 2010

Acorda Therapeutics, Inc. today announced its financial results for the third quarter of 2010.

1 Nov 2010

Humana third quarter diluted EPS increases to $2.32

Humana Inc. today reported diluted earnings per common share (EPS) for the quarter ended September 30, 2010 (3Q10) of $2.32, ahead of management's guidance of $1.65 to $1.75. The company earned $1.78 per share for the quarter ended September 30, 2009 (3Q09).

1 Nov 2010

MedWOW adds Medical Equipment Parts Finder service

MedWOW.com, the global online marketplace for medical equipment, is pleased to publicize the addition of its newest user-oriented tool: a Medical Equipment Parts Finder service. As it is often a difficult and costly process to look for replacement parts for medical equipment and devices, MedWOW's R&D staff developed this feature to streamline the search for buyers unable to find the parts they need through MedWOW's standard parts and accessories search.

1 Nov 2010